Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Assets (2021 - 2025)

Rani Therapeutics Holdings (RANI) has 5 years of Return on Assets data on record, last reported at 3.52% in Q3 2025.

  • For Q3 2025, Return on Assets fell 226.0% year-over-year to 3.52%; the TTM value through Sep 2025 reached 3.52%, down 226.0%, while the annual FY2024 figure was 1.2%, 38.0% down from the prior year.
  • Return on Assets reached 3.52% in Q3 2025 per RANI's latest filing, down from 2.55% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.41% in Q4 2021 and bottomed at 3.52% in Q3 2025.
  • Average Return on Assets over 5 years is 1.15%, with a median of 0.92% recorded in 2023.
  • Peak YoY movement for Return on Assets: fell -11bps in 2023, then tumbled -226bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.41% in 2021, then plummeted by -44bps to 0.59% in 2022, then crashed by -81bps to 1.06% in 2023, then tumbled by -33bps to 1.41% in 2024, then plummeted by -149bps to 3.52% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 3.52% in Q3 2025, 2.55% in Q2 2025, and 1.8% in Q1 2025.